Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
International Immunology|November 2, 2006
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune diseaseStefka B Petkova, Shreeram Akilesh, Thomas J Sproule, et al.Mabs|January 14, 2010
Identification of circulating neuropilin-1 and dose-dependent elevation following anti-neuropilin-1 antibody administrationYanmei Lu, Hong Xiang, Peter Liu, et al.The Journal of Biological Chemistry|November 10, 2005
Cross-species vascular endothelial growth factor (VEGF)-blocking antibodies completely inhibit the growth of human tumor xenografts and measure the contribution of stromal VEGFWei-Ching Liang, Xiumin Wu, Franklin V Peale, et al.Nature Medicine|August 6, 2013
An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapyAlicia S Chung, Xiumin Wu, Guanglei Zhuang, et al.Plos One|May 12, 2011
TMEFF2 is a PDGF-AA binding protein with methylation-associated gene silencing in multiple cancer types including gliomaKui Lin, James R Taylor, Thomas D Wu, et al.Mabs|May 25, 2016
Increased in vivo effector function of human IgG4 isotype antibodies through afucosylationQian Gong, Meredith Hazen, Brett Marshall, et al.Pharmacology Research & Perspectives|March 4, 2020
Complex formation of anti-VEGF-C with VEGF-C released during blood coagulation resulted in an artifact in its serum pharmacokineticsDaniela Bumbaca Yadav, Arthur E Reyes, Priyanka Gupta, et al.Cancer Research|April 1, 2010
A therapeutic anti-VEGF antibody with increased potency independent of pharmacokinetic half-lifeYik Andy Yeung, Xiumin Wu, Arthur E Reyes, et al.Mabs|December 18, 2014
Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule chargeBing Li, Devin Tesar, C Andrew Boswell, et al.Chemistry & Biology|August 2, 2011
The development of peptide-based tools for the analysis of angiogenesisAnna Fedorova, Kerry Zobel, Herman S Gill, et al.Pageof 5